Exploring Integration and Partner Models Between Physicians and Hospitals

Now that the implementation of electronic health records (EHRs) has been universalized, the leaders of patient care organizations are moving forward to optimize their EHRs, and to make use of the advantage that automation has brought. Numerous issues around organizational strategy, prioritization, and operational tactics remain to be resolved.

This CLE webinar will guide counsel on healthcare contracting with vendors and suppliers. The panel will examine the key provisions to be included in these contracts and offer strategies for negotiating some of the crucial provisions which may be contentious between the vendor and facility.

Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.

In this webinar, we’ll speak with Dr. Mohsen Saidinejad, Associate Professor of Emergency Medicine and Pediatrics at the David Geffen School of Medicine at UCLA. Saidinejad, who is also director of the patient experience at Harbor-UCLA Medical Center and chair of the Pediatric Committee for the American College of Emergency Physicians, will speak about his clinical and research experience using mobile and connected health tools to provide hospital aftercare for patients who have been discharged from the emergency department. He'll also discuss potential technology strategies to help engage patients with their ongoing chronic care.